Over-the-Counter Rybelsus: What Exists, What Doesn't

Rybelsus in brief

How long it lasts in your body

Its half-life runs about 1 week: by 7 d half has cleared, and after five half-lives (35 d) roughly 3% remains.

How much weight was lost in the main trial

In PIONEER 1, people with type 2 diabetes lost 3.7 kg over 26 weeks, against 1.4 kg on placebo.

How the price changes over time

Monthly prices in US dollars cover the list price and self-pay offers, with each figure read from the maker's price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, Novo Nordisk pricing, Novo Nordisk.

Every legitimate way to get Rybelsus, ranked

The cheapest options come first among the ways to get it
Route	Who it is for	What you pay
Your doctor, with insurance and the savings card	Commercial insurance that covers it	For a 1-, 2- or 3-month fill, the price may be as low as $25

Prices checked November 2026. Each price is a link to the page it comes from.

Sources: Novo Nordisk pricing, rybelsus.com, FDA.

Who qualifies

Every GLP-1 drug needs a prescription in the US. For a use approved on the label, a prescriber writes it:

Taken together with diet and exercise, it brings blood sugar down for adults with type 2 diabetes.
In adults with type 2 diabetes at high risk, it lowers the odds of a heart attack, stroke or heart-related death.

FDA label on DailyMed

Status of the Shortage

On February 21, 2025, the Shortage was resolved. Old tablets of Rybelsus are being discontinued.

Semaglutide supply, product by product
Product	FDA status	Availability
Rybelsus tablet 3 mg, 7 mg, 14 mg	To Be Discontinued	Replaced by Ozempic (semaglutide) tablets

It showed up on the FDA shortage list first in March 2022
Shortage resolved: February 21, 2025
By the April 22, 2025 deadline, state pharmacies had to stop compounding copies
Outsourcing facilities were required to stop under the May 22, 2025 deadline

Sources: FDA, api.fda.gov.

Scam signals

Licensed US pharmacies require prescriptions. A seller that does not require one is not one.
FDA approval has not been granted to compounded drugs marketed under a brand name. None counts as Ozempic, Wegovy, Mounjaro or Zepbound.
Different salt forms: semaglutide sodium and semaglutide acetate are not the same as the active ingredient in drugs that are approved.
Misleading claims: the FDA issued 30 warning letters to telehealth companies that said a product was the same as the brand.
Harm reports: 990 adverse event reports tied to compounded semaglutide are on file with the FDA.
A monthly fee without the drug led the FTC to act against one program; see the NextMed review.

Sources: Novo Nordisk pricing, rybelsus.com, FDA.

Find it in your state

Hims & Hers: It is not available in all 50 states
Noom Med: It is not available in all 50 states
NovoCare Pharmacy: Its delivery network covers all 50 states, DC, Puerto Rico

Medicaid rules make the biggest change to the route. at present, GLP-1s for weight loss are covered by 10 state Medicaid programs. Choose your state to view its drug list and prior authorization rules:

Sources: hims.com, noom.com, NovoCare.